| Operating revenue and expenses | — | — |
| Operating revenue | 31,124.69a | 30,869.71a |
| Other gains and losses | -3.95a | 36.47a |
| Cost of materials | -17,847.62a | -18,159.87a |
| Change in stock of biological assets at cost, raw materials and finished products | -921.19a | -729.84a |
| Salaries and other personnel costs | -4,613.34a | -4,241.03a |
| Other operating expenses | -5,197.55a | -4,540.72a |
| EBITDA before fair value adjustments related to biological assets | 4,383.43a | 4,694.41a |
| Depreciation on intangibles | -32.37a | -33.61a |
| Depreciation on right-of-use assets | -661.1a | -588.79a |
| Depreciation on fixed assets | -958.74a | -861.49a |
| Impairment loss on intangibles | -73.54a | -4a |
| Impairment loss on fixed assets | -15a | -104.11a |
| Operating profit before fair value adjustments related to biological assets | 2,672.68a | 3,102.41a |
| Fair value adjustments related to biological assets | 291.59a | 124.96a |
| Operating profit (EBIT) | 2,964.27a | 3,227.37a |
| Associates and net financial items | — | — |
| Income from joint ventures and associates | 106.84a | -143.31a |
| Net financial items | -516.97a | -483.96a |
| Profit before tax | 2,554.13a | 2,600.11a |
| Ordinary corporate tax cost | -632.37a | -608.54a |
| Resource rent tax cost | -771.52a | -1,781.02a |
| Annual profit | 2,693.28a | 210.55a |
| Of which controlling interests | 2,673.48a | 272.5a |
| Of which non-controlling interests | 19.81a | -61.95a |